Malonate-induced degeneration of basal forebrain cholinergic neurons: Attenuation by lamotrigine, MK-801, and 7-nitroindazole

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1191-1199

  Connop, B P ^a   Boegman, R J ^a   Beninger, R J ^a   Jhamandas, K ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

7 Nitroindazole; Cholinergic toxicity; Lamotrigine; Malonate; N( ) Nitro L arginine; Nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; DIZOCILPINE; LAMOTRIGINE; MALONIC ACID; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FOREBRAIN; HISTOCHEMISTRY; INFUSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ANIMALIA;

EID: 0031016933     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031191.x     Document Type: Article

References (47)

1. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42, 733-738.
2. Bazzett T. J., Falik R. C., Becker J. B., and Albin R. L. (1995) Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunore-activity in rat striatum. Exp. Neurol. 134, 244-252.
3. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
4. Beal M. F. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16, 125-131.
5. Beal M. F. (1994) Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle. Neurobiol. Aging 15 (Suppl.), S171-S174.
6. Beal M. F., Brouillet E., Jenkins B. G., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R., and Hyman B. T. (1993a) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181-4192.
7. Beal M. F., Brouillet E., Jenkins B., Henshaw R., Rosen B., and Hyman B. T. (1993b) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 1147-1150.
8. Benzing W. C. and Mufson E. J. (1995) Increased number of NADPH-d-positive neurons within the substantia innominata in Alzheimer's disease. Brain Res. 670, 351-355.
9. Bierer L. M., Haroutunian V., Gabriel S., Knott P. J., Carlin L. S., Purohit D. P., Perl D. P., Schmeidler J., Kanof P., and Davis K. L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
10. Boegman R. J., Cockhill J., Jhamandas K., and Beninger R. J. (1992) Excitotoxic lesions of rat basal forebrain: differential effects on choline acetyltransferase in the cortex and amygdala. Neuroscience 51, 129-135.
11. Butcher L. L. and Bilezikjian L. (1975) Acetylcholinesterase-containing neurons in the neostriatum and substantia nigra revealed after punctate intracerebral injection of diisopropylfluorophosphate. Eur. J. Pharmacol. 34, 115-125.
12. Connop B. P., Rolfe N. G., Boegman R. J., Jhamandas K., and Beninger R. J. (1994) Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology 33, 1439-1445.
13. Connop B. P., Boegman R. J., Jhamandas K., and Beninger R. J. (1995) Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res. 676, 124-132.
14. Connop B. P., Boegman R. J., Beninger R. J., and Jhamandas K. (1996) Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase. Neuropharmacology 35, 459-465.
15. Coyle J. T., Price D. L., and DeLong M. R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1189.
16. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
17. Dawson V. L., Kizushi V. M., Huang P. L., Snyder S. H., and Dawson T. M. (1996) Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16, 2479-2487.
18. Demerlé-Pallardy C., Lonchampt M., Chabrier P., and Braquet P. (1991) Absence of implication of L-arginine/nitric oxide pathway on neuronal cell injury induced by L-glutamate or hypoxia. Biochem. Biophys. Res. Commun. 181, 456-464.
19. Fonnum F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24, 407-409.
20. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 61-67.
21. Greene J. G. and Greenamyre J. T. (1995) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 430-436.
22. Greene J. G., Porter R. H. P., Eller R. V., and Greenamyre J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61, 1151-1154.
23. Henshaw R., Jenkins B. G., Schulz J. B., Ferrante R. J., Kowall N. W., Rosen B. R., and Beal M. F. (1994) Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Res. 647, 161-166.
24. Huang Z., Huang P. L., Fishman M. C., and Moskowitz M. A. (1996) Focal cerebral ischemia in mice deficient in either endothelial (eNOS) or neuronal nitric oxide (nNOS) synthase. Stroke 27, 173.
25. Kaneko I., Yamada N., Sakuraba Y., Kamenosono M., and Tutumi S. (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65, 2585-2593.
26. Karnovsky M. J. and Roots L. (1964) A 'direct-coloring' thiocholine method for cholinesterase. J. Histochem. Cytochem. 12, 219-221.
27. Kennedy A. M., Frackowiak R. S. J., Newman S. K., Bloomfield P. M., Seaward J., Roques P., Lewington G., Cunningham V. J., and Rossor M. N. (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186, 17-20.
28. Lees G. J. (1991) Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Rev. 16, 283-301.
29. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. MacKenzie G. M., Rose S., Bland-Ward P. A., Moore P. K., Jenner P., and Marsden C. D. (1994) Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport 5, 1993-1996.
31. Maragos W. F. and Silverstein F. S. (1995) Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. J. Neurochem. 64, 2362-2365.
32. Marey-Semper I., Gelman M., and Lévi-Strauss M. (1995) A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15, 5912-5918.
33. Meldrum B. S. (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44 (Suppl.), S14-S23.
34. Messam C. A., Greene J. G., Greenamyre J. T., and Robinson M. B. (1995) Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801. Brain Res. 684, 221-224.
35. Novelli A., Reilly J. A., Lysko P. G., and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
36. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
37. Reiman E. M., Caselli R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N., and Osborne D. (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the ∈4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752-758.
38. Salter M., Duffy C., and Hazelwood R. (1995) Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology 34, 327-334.
39. Salter M., Duffy C., Garthwaite J., and Strijbos P. J. L. M. (1996) Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J. Neurochem. 66, 1683-1690.
40. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., and Beal M. F. (1995a) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.
41. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E., and Beal M. F. (1995b) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
42. Schulz J. B., Matthews R. T., Henshaw D. R., and Beal M. F. (1996a) Neuroprotective strategies for the treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71, 1043-1048.
43. Schulz J. B., Huang P. L., Matthews R. T., Passov D., Fishman M. C., and Beal M. F. (1996b) Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67, 430-433.
44. Wüllner U., Young A. B., Penney J. B., and Beal M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 1772-1781.
45. Zeevalk G. D. and Nicklas W. J. (1990) Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253, 1285-1292.
46. Zeevalk G. D., Derr-Yellin E., and Nicklas W. J. (1995a) Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther. 275, 1124-1130.
47. Zeevalk G. D., Derr-Yellin E., and Nicklas W. J. (1995b) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64, 455-458.